In each issue of Pharmaceutical Engineering®, we introduce a member of the ISPE staff who provides ISPE members with key information and services. Meet Lynda Goldbach, Manager of Publications, Publications Department.
I work primarily on our Guidance Documents, assisting our volunteer teams through the development process, and manage the publication of all the guides. I also do the final production for both print and electronic versions. I used to work on PE magazine, in the marketing department producing our brochures, newsletters, and other promotional pieces, and managed our member database when we had a lot fewer members.
I love working with our members and learning about all the different areas of the pharmaceutical industry. One of my favorite things is taking the rough-looking guide drafts and turning them into a real “book.”
I like to spend time with my husband and daughters, either at home crafting or at Disney World (our “second home”). I also enjoy teaching tricks and agility moves to our two Australian shepherds.
On October 29, 1986, a nervous teenager started her first day at ISPE. She was hired to perform data entry on a temporary, part-time basis. At the time, there were six people on staff, including the new hire and Executive Director Bob Best, and less than 2,000 members. The small staff size meant it would be “all hands on deck” for every facet of operations. It also meant that this new part-timer had the opportunity to learn anything she wanted to about ISPE—and so she did. She worked on Pharmaceutical Engineering, produced countless materials for the marketing department, and managed the member database. Eventually, she found her home in Guidance Documents in 1998.
Thirty-five years, four CEOs, 46 ISPE employees, and 16,000 members later, this nervous teenager has evolved into one of the most important contributors to ISPE as an organization, and to the industry as a whole. A skilled graphic designer and production/layout professional, her mark is on all Guidance Documents produced by ISPE, with the exception of one (if you’re curious, the first Baseline Guide on Bulk Pharmaceutical Chemicals). She’s collaborated with hundreds of volunteers to develop our prestigious ISPE Guidance Documents, the gold standard in the industry. To date, she has worked on a total of 240 unique products in the Guidance Documents space, including bound, PDF, CD, and myriad translated editions!
Please join me in thanking Lynda for her dedication and contributions to the organization and industry and congratulating her on a very happy 35th ISPE Work Anniversary!
Rochelle May, Senior Director, PublicationsThrough the ISPE Foundation Professional Development Grant program, Silas Tamufor attended the 2023 ISPE Annual Meeting & Expo in October 2023. Tamufor is a PhD student and ISPE Boston Chapter member who began serving as the ISPE Boston Educational Programs Committee Chair in December 2023. He, along with 87 other students and recent graduates, attended the conference thanks to the...
To meet the biopharmaceutical industry’s duty to manufacture safe and effective therapies for patients, a robust quality system is fundamental to success. A quality system should link to quality culture and prioritize focusing on quality, led by management, that fosters sustainable compliance and consistent production of high-quality drugs. Strong quality culture attributes include a proactive...
Stability sampling and testing are key to ensuring that products maintain safety, identity, strength, purity, and quality throughout their claimed shelf life. It is also a regulatory requirement per ICH Q5. However, storing product samples in different environmental conditions, testing those samples for three to five years (or more) after initial manufacture, and properly analyzing and...